Sweet Syndrome Following SARS-CoV2 Vaccination
Vaccines are today considered one of the most effective means against the Sars-CoV-2 pandemic. The BNT162b2 vaccine by Pfizer/BioNTech has been massively administered throughout the globe; since its approval, a wide spectrum of cutaneous reactions has been reported. Here we report the case of a 52-y...
Guardado en:
Autores principales: | Maria Efenesia Baffa, Roberto Maglie, Neri Giovannozzi, Francesca Montefusco, Stefano Senatore, Daniela Massi, Emiliano Antiga |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/382109afaae34e4cb9080019238e003d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Association between vaccination with the BNT162b2 mRNA COVID-19 vaccine and Bell's palsy: a population-based study
por: Rana Shibli, et al.
Publicado: (2021) -
Self-Reported Adverse Events of COVID-19 Vaccines in Polish Healthcare Workers and Medical Students. Cross-Sectional Study and Pooled Analysis of CoVaST Project Results in Central Europe
por: Arkadiusz Dziedzic, et al.
Publicado: (2021) -
Pediatric sweet syndrome
por: Albert E. Zhou, et al.
Publicado: (2021) -
The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview
por: Bruna Aparecida Souza Machado, et al.
Publicado: (2021) -
Myocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age and Vaccine Types
por: Minghui Li, et al.
Publicado: (2021)